Arnold J. Reuser

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Lentiviral Hematopoietic Stem Cell Gene Therapy Corrects Murine Pompe Disease.

Lentiviral Hematopoietic Stem Cell Gene Therapy Corrects Murine Pompe Disease.

Journal: Molecular therapy. Methods & clinical development

Published: January 24, 2020

GAA variants and phenotypes among 1,079 patients with Pompe disease: Data from the Pompe Registry.

GAA variants and phenotypes among 1,079 patients with Pompe disease: Data from the Pompe Registry.

Journal: Human mutation

Published: October 09, 2018

Childhood Pompe disease: clinical spectrum and genotype in 31 patients.

Childhood Pompe disease: clinical spectrum and genotype in 31 patients.

Journal: Orphanet journal of rare diseases

Published: March 03, 2016

Effects of a higher dose of alglucosidase alfa on ventilator-free survival and motor outcome in classic infantile Pompe disease: an open-label single-center study.

Effects of a higher dose of alglucosidase alfa on ventilator-free survival and motor outcome in classic infantile Pompe disease: an open-label single-center study.

Journal: Journal of inherited metabolic disease

Published: June 05, 2015

Safety and efficacy of exercise training in adults with Pompe disease: evalution of endurance, muscle strength and core stability before and after a 12 week training program.

Safety and efficacy of exercise training in adults with Pompe disease: evalution of endurance, muscle strength and core stability before and after a 12 week training program.

Journal: Orphanet journal of rare diseases

Published: March 17, 2015

Lentiviral Stem Cell Gene Therapy for Pompe Disease.

Lentiviral Stem Cell Gene Therapy for Pompe Disease.

Journal: Journal of neuromuscular diseases

Published: January 01, 2015

Quality of Life and Participation in the Daily Life (Activities) of Adults with Pompe Disease Receiving Enzyme Replacement Therapy: 10 Years of International Follow-Up.

Quality of Life and Participation in the Daily Life (Activities) of Adults with Pompe Disease Receiving Enzyme Replacement Therapy: 10 Years of International Follow-Up.

Journal: Journal of neuromuscular diseases

Published: January 01, 2015

Quality of life and participation in daily life of adults with Pompe disease receiving enzyme replacement therapy: 10 years of international follow-up.

Quality of life and participation in daily life of adults with Pompe disease receiving enzyme replacement therapy: 10 years of international follow-up.

Journal: Journal of inherited metabolic disease

Published: August 07, 2014

Newborn screening for pompe disease? a qualitative study exploring professional views.

Newborn screening for pompe disease? a qualitative study exploring professional views.

Journal: BMC pediatrics

Published: January 30, 2014

Enzyme therapy and immune response in relation to CRIM status: the Dutch experience in classic infantile Pompe disease.

Enzyme therapy and immune response in relation to CRIM status: the Dutch experience in classic infantile Pompe disease.

Journal: Journal of inherited metabolic disease

Published: November 15, 2013

Rupture of the middle cerebral artery aneurysm as a presenting symptom of late-onset Pompe disease in an adult with a novel GAA gene mutation.

Rupture of the middle cerebral artery aneurysm as a presenting symptom of late-onset Pompe disease in an adult with a novel GAA gene mutation.

Journal: Acta neurologica Belgica

Published: October 22, 2013

Novel GAA sequence variant c.1211 A>G reduces enzyme activity but not protein expression in infantile and adult onset Pompe disease.

Novel GAA sequence variant c.1211 A>G reduces enzyme activity but not protein expression in infantile and adult onset Pompe disease.

Journal: Gene

Published: August 06, 2013

Showing 1-12 of 35

Last Updated: 09/26/2026